Menopause causes osteoporosis primarily because estrogen, which acts as a brake on bone breakdown, drops sharply and stays low. Without that brake, bone-dissolving cells live longer, work harder, and multiply faster than bone-building cells can keep up with. The result is a net loss that can exceed 10% of total bone mass in the five years surrounding a woman’s final menstrual period.
To understand why this happens, it helps to know that bone is not a static structure. Your skeleton is constantly being torn down and rebuilt in a process called remodeling. Before menopause, estrogen keeps that process balanced. After menopause, the balance tips decisively toward destruction.
How Estrogen Keeps Bone Intact
Bone remodeling depends on two types of cells working in tandem. One type breaks down old bone, and the other type builds new bone in its place. Estrogen controls this cycle largely through a signaling system that determines how many bone-dissolving cells get created in the first place.
Cells lining the surface of bone produce a protein that acts as a “go” signal, telling the body to create more bone-dissolving cells. Estrogen suppresses this signal. At the same time, bones produce a decoy molecule that intercepts the “go” signal before it can do its job, essentially acting as a natural off-switch. When estrogen levels are healthy, the off-switch dominates. Bone gets broken down at a measured pace, and building cells have time to replace what’s lost.
Estrogen also shortens the lifespan of bone-dissolving cells by promoting their natural death. Research published in Nature Medicine found that estrogen increases the rate of this programmed cell death by two- to threefold. So estrogen works on two fronts: it limits how many bone-dissolving cells are born, and it makes sure the ones that do form die off quickly before they can remove too much bone.
What Changes When Estrogen Drops
When estrogen declines during menopause, both of those protective mechanisms fail at once. The “go” signal for bone-dissolving cells is no longer suppressed, so production ramps up. And the cells that do form live longer, giving each one more time to chew through bone tissue. The combination is significant: more bone-dissolving cells, each working longer shifts.
Estrogen deficiency also triggers a rise in inflammatory molecules, including interleukin-1, interleukin-6, and tumor necrosis factor-alpha. These are the same chemicals your immune system uses during infection or injury, and they independently stimulate bone breakdown. The inflammatory environment compounds the direct loss of estrogen’s protective effects, creating a kind of double hit to the skeleton.
Calcium Absorption Declines Too
The damage isn’t limited to what happens inside bone. Estrogen also plays a direct role in how efficiently your gut absorbs calcium from food. The duodenum, the first stretch of your small intestine, is the primary site where dietary calcium enters the bloodstream. This process depends on specific transport proteins embedded in the intestinal lining, and estrogen regulates their production.
A 2025 study in Scientific Reports found that postmenopausal women had significantly lower levels of these calcium transport proteins in their duodenal tissue compared to younger women, and the reduction correlated directly with lower bone mineral density. In animal models, supplementing estrogen restored calcium absorption and improved bone density, confirming the link. So after menopause, your body is simultaneously losing more bone and absorbing less of the mineral it needs to rebuild.
Where and How Fast Bone Is Lost
Bone loss doesn’t happen evenly across the skeleton. The interior of bones contains a spongy, lattice-like structure that provides much of a bone’s strength. This is the first tissue to suffer. The lattice gets thinner, individual struts get perforated and disconnected, and the overall density drops. Meanwhile, the hard outer shell of bone develops increased porosity as tiny canals within it widen from unbalanced remodeling. Both types of deterioration reduce fracture resistance.
The timing follows a predictable pattern. Data from a multiethnic cohort study tracking women through the menopausal transition found that bone density changes little during the early stages. The real acceleration begins in late perimenopause, the phase just before periods stop entirely. At that point, women lose an average of 0.018 g/cm² per year from the spine and 0.010 g/cm² per year from the hip. After the final period, the pace stays similar or increases slightly, with spine losses averaging 0.022 g/cm² per year and hip losses 0.013 g/cm² per year. This rapid phase typically lasts five to seven years before the rate of loss gradually slows.
How Bone Density Is Measured
Bone density is assessed with a scan that produces a number called a T-score, which compares your bones to the peak bone density of a healthy young adult. A T-score of negative 1 or higher is considered healthy. A score between negative 1 and negative 2.5 indicates osteopenia, a milder form of bone thinning. A score of negative 2.5 or lower means osteoporosis.
The US Preventive Services Task Force recommends routine screening for all women at age 65 and older. Postmenopausal women younger than 65 should be screened if they have additional risk factors such as low body weight, a parent who fractured a hip, smoking, or heavy alcohol use. If any of those apply, a clinical risk assessment tool can help determine whether a bone density scan is warranted.
Why Hormone Therapy Reduces Fractures
Because estrogen loss is the central driver, replacing estrogen addresses the problem at its source. The Women’s Health Initiative, the largest randomized trial of menopausal hormone therapy, found that treatment reduced the risk of any fracture by 28%, major osteoporotic fractures (spine, hip, forearm, and upper arm) by 40%, and hip fractures specifically by 34%. These reductions held across a wide range of baseline fracture risk, meaning women at both lower and higher risk benefited.
Hormone therapy is not the only option, and it carries its own risks that vary by age, timing, and individual health history. But the fracture data illustrate how central estrogen is to the problem. Remove it, and bones deteriorate. Restore it, and the deterioration slows or stops. Other treatments for osteoporosis work through different mechanisms, but estrogen replacement is the one that directly reverses the hormonal shift menopause creates.
Why Some Women Are Affected More Than Others
Not every woman who goes through menopause develops osteoporosis. The risk depends heavily on how much bone you had to begin with. Women who built a higher peak bone density during their teens and twenties, through genetics, physical activity, and adequate calcium and vitamin D, have more to lose before crossing the threshold into osteoporosis. Women who enter menopause with lower reserves reach that threshold faster.
Early menopause, whether natural or surgical, is a particularly strong risk factor because it extends the number of years the skeleton spends without estrogen’s protection. Body weight matters too: fat tissue produces small amounts of estrogen even after the ovaries stop, which provides a modest buffer. This is one reason why women with very low body weight face higher fracture risk. Smoking accelerates bone loss independently and also tends to lower estrogen levels, compounding the effect.